UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation

Journal of fungi (Basel), 2023-03, Vol.9 (3), p.387

2023

Volltextzugriff (PDF)

Invasive fungal infections in the pediatric population

Expert review of anti-infective therapy, 2011-03, Vol.9 (3), p.275-278

2011

Volltextzugriff (PDF)

Extended Dosing Regimens for Fungal Prophylaxis

Clinical microbiology reviews, 2019-06, Vol.32 (3)

2019

Volltextzugriff (PDF)

Resources for Medical Mycology on the World Wide Web

Clinical infectious diseases, 2005-02, Vol.40 (3), p.437-450, Article 437

2005

Volltextzugriff (PDF)

Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population

Frontiers in microbiology, 2018-03, Vol.9, p.518-518

2018

Volltextzugriff (PDF)

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.761-767

2019

Volltextzugriff (PDF)

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

Clinical infectious diseases, 2019-05, Vol.68 (Supplement_4), p.S260-S274

2019

Volltextzugriff (PDF)

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

The Journal of infectious diseases, 2003-06, Vol.187 (12), p.1834-1843

2003

Volltextzugriff (PDF)

Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study

Frontiers in microbiology, 2019-04, Vol.10, p.681-681

2019

Volltextzugriff (PDF)

Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients

Journal of antimicrobial chemotherapy, 2022-07, Vol.77 (8), p.2209-2216

2022

Volltextzugriff (PDF)

Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy

Antimicrobial agents and chemotherapy, 2021-01, Vol.65 (2)

2021

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4116-4123

2010

Volltextzugriff (PDF)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

Clinical infectious diseases, 2019-05, Vol.68 (Supplement_4), p.S244-S259

2019

Volltextzugriff (PDF)

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation

Clinical infectious diseases, 2020-06, Vol.71 (1), p.226-236

2020

Volltextzugriff (PDF)

Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1340-1348

2016

Volltextzugriff (PDF)

Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer

Clinical infectious diseases, 2023-02

2023

Volltextzugriff (PDF)

Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial

International journal of antimicrobial agents, 2020-09, Vol.56 (3), p.106084, Article 106084

2020

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children

Antimicrobial agents and chemotherapy, 2016-12, Vol.60 (12), p.7340-7346

2016

Volltextzugriff (PDF)

Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System

The Journal of infectious diseases, 2000-07, Vol.182 (1), p.274-282

2000

Volltextzugriff (PDF)

Invasive Aspergillosis in Children With Acquired Immunodeficiencies

Clinical infectious diseases, 2012-01, Vol.54 (2), p.258-267

2012

Volltextzugriff (PDF)

Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.12-23

2002

Volltextzugriff (PDF)

Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers

Journal of fungi (Basel), 2021-07, Vol.7 (8), p.604

2021

Volltextzugriff (PDF)

Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia

Antimicrobial Agents and Chemotherapy, 2001-03, Vol.45 (3), p.857-869

2001

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Aktive Filter

ThemaMicrobiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(418)
Mit Volltextzugriff
(409)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(420)
Life Sciences & Biomedicine
(417)
Humans
(168)
Infectious Diseases
(139)
Pharmacology & Pharmacy
(137)
Antifungal Agents
(129)
Biological And Medical Sciences
(128)
Medical Sciences
(111)
Mycology
(100)
Animals
(91)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(84)
Pharmacology. Drug Treatments
(84)
Antifungal Agents - Therapeutic Use
(83)
Female
(77)
Infections
(74)
Fungal Infections
(73)
Immunology
(68)
Aspergillosis
(62)
Aspergillus
(61)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation

Invasive fungal infections in the pediatric population

Extended Dosing Regimens for Fungal Prophylaxis

Resources for Medical Mycology on the World Wide Web

Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study

Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients

Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation

Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer

Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients

Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children

Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System

Invasive Aspergillosis in Children With Acquired Immunodeficiencies

Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers

Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia

Aktive Filter

Suchergebnisse filtern